Effect of 1,25(OH)2D3 on rat peritoneal mesothelial cells treated with high glucose plus lipopolysaccharide

被引:15
作者
Yang, Lina [1 ]
Wang, Jun [1 ]
Fan, Yi [1 ]
Chen, Shuo [1 ]
Wang, Lining [1 ]
Ma, Jianfei [1 ]
机构
[1] China Med Univ, Affiliated Hosp 1, Dept Nephrol, Shenyang 110001, Liaoning, Peoples R China
关键词
1,25(OH)(2)D-3; VDR; High glucose; Lipopolysaccharide; Rat peritoneal mesothelial cells; GROWTH-FACTOR-BETA; VITAMIN-D; IN-VITRO; 1,25-DIHYDROXYVITAMIN D-3; TGF-BETA; RECEPTOR; EXPRESSION; TGF-BETA-1; ADHESION; GENE;
D O I
10.1016/j.cellimm.2011.06.017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
1,25(OH)(2)D-3, the active metabolite of vitamin D-3, its activity is not limited to mineral and skeletal homeostasis. In recent years, there has been increasing evidence pointing to the role of its activity in the regulation of cell proliferation, cell differentiation and immunomodulation. Here we report lipopolysaccharide (LPS), a glycolipid that is produced and secreted by gram-negative bacteria during peritonitis, plus high glucose (HG) can significantly inhibit mesothelial cell viability while induce more apoptosis in rat peritoneal mesothelial cells (RPMC). Pretreatment with 1,25(OH)(2)D-3 can reverse the above effect in a concentration dependent manner. HG plus LPS can down-regulate the levels of both mRNA and protein of VDR, and up-regulate the expression of TGF-beta 1 and TNF-alpha in RPMC, which can also be effectively reversed by pretreatment with 1,25(OH)(2)D-3. The above results suggest that HG plus LPS may induce changes in RPMC's viability and apoptosis, leading to peritoneal injury. 1,25(OH)(2)D-3 can reverse the inhibition of cell viability, the increase of apoptotic rate and induction of fibrosis related cytokine TGF-beta 1 and TNF-alpha by HG plus LPS in RPMC, thus protect peritoneal membrane. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:173 / 179
页数:7
相关论文
共 40 条
  • [1] Cutting edge: Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages
    Akashi, S
    Shimazu, R
    Ogata, H
    Nagai, Y
    Takeda, K
    Kimoto, M
    Miyake, K
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (07) : 3471 - 3475
  • [2] ALROY I, 1995, MOL CELL BIOL, V15, P5789
  • [3] Anderson P H, 2003, Clin Biochem Rev, V24, P13
  • [4] Aoudjit F, 1997, CELL GROWTH DIFFER, V8, P335
  • [5] 1,25-(OH2)D3 alters the transforming growth factor β signaling pathway in renal tissue
    Aschenbrenner, JK
    Sollinger, HW
    Becker, BN
    Hullett, DA
    [J]. JOURNAL OF SURGICAL RESEARCH, 2001, 100 (02) : 171 - 175
  • [6] The transcriptional role of Smads and FAST (FoxH1) in TGFβ and activin signalling
    Attisano, L
    Silvestri, C
    Izzi, L
    Labbé, E
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 180 (1-2) : 3 - 11
  • [7] TGF-β and fibrosis
    Branton, MH
    Kopp, JB
    [J]. MICROBES AND INFECTION, 1999, 1 (15) : 1349 - 1365
  • [8] Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats
    Calle, Consuelo
    Maestro, Begona
    Garcia-Arencibia, Moises
    [J]. BMC MOLECULAR BIOLOGY, 2008, 9
  • [9] Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285
  • [10] What really happens to people on long-term peritoneal dialysis?
    Davies, SJ
    Phillips, L
    Griffiths, AM
    Russell, LH
    Naish, PF
    Russell, GI
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (06) : 2207 - 2217